Talis Biomedical Corp
TLISDelisted Sep 20, 2024- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001584751
Talis Biomedical Corp was delisted on Sep 20, 2024; its insiders filed their last Form 4 on Sep 9, 2024; 18 institutions reported holding it in 13F filings for Q2 2024, worth $6.84M in total; Greenlight Capital was the only superinvestor holding it.
Superinvestors holding TLIS, Q2 2024
1 superinvestor reports holding Talis Biomedical Corp on Form 13F, worth $1.29M in total. Weight is Talis Biomedical Corp's share of each 13F portfolio; actions compare shares with Q1 2024.
| Superinvestor | % of portfolio | Shares | Value | vs. previous quarter |
|---|---|---|---|---|
| Greenlight CapitalDavid Einhorn | 0.1% | 149,052 | $1.29M | Unchanged |
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of TLIS each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q1 2022
1 superinvestor holding at quarter end
- Added
- Greenlight Capital (+42.5%)
Q4 2021
1 superinvestor holding at quarter end